SCHEMBL2179786

SCHEMBL2179786

COc1ccc2cc(-c3ccnc(NCC(C)(C)CN(C)C)n3)cc(N3CCNCC3)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.44
HRH4 Q9H3N8 3/20 0.42
PRKD3 O94806 3/20 0.41
MAPK9 P45984 2/20 0.41
CSNK1A1 P48729 2/20 0.41
CSNK1D P48730 2/20 0.41
GSK3B P49841 2/20 0.41
PRKD2 Q9BZL6 2/20 0.41
MAP4K4 O95819 1/20 0.41
MAPK8 P45983 1/20 0.41
CSNK1G2 P78368 1/20 0.41
CSNK1G1 Q9HCP0 1/20 0.41
CSNK1G3 Q9Y6M4 1/20 0.41
CDK2 P24941 3/20 0.41
CLK4 Q9HAZ1 1/20 0.41
PIM2 Q9P1W9 1/20 0.41
HRH3 Q9Y5N1 1/20 0.40
IKBKB O14920 1/20 0.38
CHUK O15111 1/20 0.38
HTR6 P50406 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2177926 0.90 MTOR (0.44) PRKD3MAPK9CSNK1A1CSNK1DGSK3B
SCHEMBL2179362 0.86 MKNK1 (0.51) NCF1HRH4PRKD3CDK2IKBKB
SCHEMBL2176460 0.86 MKNK1 (0.47) NCF1HRH4PRKD3CDK2IKBKB
SCHEMBL2182169 0.84 DYRK1A (0.53) NCF1HRH4PRKD3MAPK9CDK2
SCHEMBL2175103 0.83 NCF1 (0.48) NCF1HRH4PRKD3MAPK9CSNK1A1
SCHEMBL2176027 0.82 NCF1 (0.54) NCF1PRKD3CDK2IKBKBCHUK
SCHEMBL2175724 0.82 NCF1 (0.48) NCF1HRH4PRKD3CDK2IKBKB
Hydrochloric Acid SCHEMBL2177589 0.81 NCF1 (0.53) NCF1PRKD3CDK2IKBKBCHUK
SCHEMBL10272914 0.81 DYRK1A (0.50) NCF1MAPK9CLK4HTR6MKNK1
SCHEMBL2180327 0.81 CCNT1 (0.49) NCF1PRKD3MAPK9CDK2CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US claimed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed
WO-2011082268-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ARQULE INC. (US) 2011-07-07 WO disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP NCF1 272/4885HRH4 2409/4885PRKD3 1149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.